Guardant Health offers blood and tissue tests for cancer screening, treatment selection and disease monitoring. It last closed at $143.28 on Nov 17, down 0.52% on the day. GH last reported earnings on Thu, Nov 5, 2026. The average 12-month price target from 8 analysts is $206.00 (+43.8% from the last close), with a high of $225.00 and a low of $190.00. Analyst consensus is Strong Buy, based on the latest ratings from 8 firms (8 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 18 whale options trades in GH, 44% of them bullish and 56% bearish. In the past 30 days there were 18 dark pool prints totaling $49.0M, the largest $11.6M.
Each firm's latest rating on GH in the past 90 days
Average 12-month target
$206.00
▲ 43.8% upside
Based on 8 analysts who set a price target on GH in the past 90 days. The average target is $206.00, with a high of $225.00 and a low of $190.00, compared with the last close of $143.28.
Low $190.00Avg $206.00High $225.00
Blue marker: last close $143.28
Highest target$225.00
Average target$206.00
Lowest target$190.00
Latest rating changes
Piper SandlerTarget lowered
Nov 10Buy$193 → $190
BTIGTarget raised
Oct 27Buy$195 → $210
Roth CapitalInitiated
Oct 23Buy$200
Morgan StanleyTarget raised
Oct 13Buy$185 → $200
BarclaysTarget raised
Oct 7Buy$200 → $220
Date
Firm
Action
Rating
Price target
Nov 10
Piper Sandler
Target lowered
Buy
$193 → $190
Oct 27
BTIG
Target raised
Buy
$195 → $210
Oct 23
Roth Capital
Initiated
Buy
$200
Oct 13
Morgan Stanley
Target raised
Buy
$185 → $200
Oct 7
Barclays
Target raised
Buy
$200 → $220
Loading…
Technical Analysis
GH · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend, nearing oversold
The stock is 14% below its 20 day and 17% below its 50 day average. It is 7% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 34), near oversold. The nearest support is the swing low (Jul 29) at $140.86, and the nearest resistance the Pivot at $144.42.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 6.5%/day
Key levels
$191.0552 week high+33.3%
$167.9550 day average+17.2%
$163.9120 day average+14.4%
$163.85100 day average+14.4%
$163.39Swing high (Nov 11)+14.0%
$147.81Pivot R1+3.2%
$144.42Pivot+0.8%
$143.28Last close
$140.86Swing low (Jul 29)−1.7%
$139.89Pivot S1−2.4%
$133.08200 day average−7.1%
$74.5552 week low−48.0%
Indicators
RSI (14)
33.84
Weak, oversold below 30
Neutral
MACD
-5.93
Below its signal line
Bearish
Stochastic
20.1
Middle of its range
Neutral
ADX (14)
21.3
Weak trend
Williams %R
-86.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-123.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−18.1%
Change over 10 sessions
Bearish
ATR (14)
$9.37
Typical daily range, 6.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityNormal, 12.1%/day
Key levels
$191.0552 week high+33.3%
$167.9550 day average+17.2%
$163.9120 day average+14.4%
$163.85100 day average+14.4%
$163.39Swing high (Nov 11)+14.0%
$147.81Pivot R1+3.2%
$144.42Pivot+0.8%
$143.28Last close
$140.86Swing low (Jul 29)−1.7%
$139.89Pivot S1−2.4%
$133.08200 day average−7.1%
$74.5552 week low−48.0%
Indicators
RSI (14)
46.97
Middle of its range
Neutral
MACD
8.10
Below its signal line
Bearish
Stochastic
22.4
Middle of its range
Neutral
ADX (14)
35.7
Trending down
Williams %R
-87.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-183.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−9.0%
Change over 10 sessions
Bearish
ATR (14)
$17.40
Typical daily range, 12.2% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200–
What happened before, for GH
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how GH did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Whale flow is mixed8 bullish and 10 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow GH usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How GH has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GH is in one of them and how their past GH trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Guardant Health
Guardant Health is a precision oncology company based in Palo Alto, California. It offers blood and tissue tests that help doctors choose treatments for patients with advanced cancer, monitor for residual or returning disease after early stage treatment, and screen adults for colorectal cancer. The company also provides its tests and AI-based data analytics tools to biopharmaceutical companies running clinical studies and drug development. Its customers include oncologists, physicians, health systems and drug developers.